SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

ADCT

ADC Therapeutics S.A.
NYSEHealth Care

Latest close: 1.40 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Oct 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗
  2. Aug 13, 2026Quarterly report · 10-QFiled by the company itself.Open the filing ↗
  3. Aug 13, 2026Material event · 8-KFiled by the company itself.Open the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record39215 flagged findings
Reported transactions (Form 4)73since Jan 3, 2024 · and 40 other holdings
Corporate events (8-K)13since Jan 19, 2024

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 392)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Oct 13, 268-K ↗Current report · Entered a material agreement new
  • Aug 14, 26SCHEDULE 13G ↗Passive stake · Nantahala Capital Management, LLC · 9.7% · event on Jun 30, 26
  • Aug 13, 2610-Q ↗Quarterly report
  • Aug 13, 268-K ↗Current report · Results · Communication to the market
  • Jul 27, 26SCHEDULE 13G ↗Passive stake · BlackRock, Inc. · 5.4% · event on Jun 30, 26
  • Insider transaction · 4 Form 4 filingsshow all 4hide
  • Jul 2, 268-K ↗Current report · A senior executive left or was appointed
  • Jun 24, 268-K ↗Current report · Communication to the market · Other events
  • Insider transaction · 7 Form 4 filingsshow all 7hide
  • Jun 3, 268-K ↗Current report · Communication to the market · Other events
  • Jun 2, 268-K ↗Current report · Shareholder vote results
  • May 4, 2610-Q ↗Quarterly report
  • May 4, 268-K ↗Current report · Results
  • Apr 24, 26SCHEDULE 13G/A ↗Passive stake · Redmile Group, LLC · 9.9% · event on Apr 20, 26 · amendment
  • Apr 20, 26DEF 14A ↗Shareholder meeting and votes
  • Apr 20, 26DEFA14A ↗Shareholder meeting and votes

392 filings on record, the oldest from Jul 25, 19.

Listing the 25 most recent filings of the 392 on record.

8-Ks, explained

Stress1Structure10Governance2
  • Oct 13, 26StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Jul 2, 26GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 23, 26StructureSold unregistered shares+2 more in the same filing8-K 3.02 ↗
  • Oct 14, 25StructureSold unregistered shares+3 more in the same filing8-K 3.02 ↗
  • Jun 12, 25StressRestructuring plan with committed costs+3 more in the same filing8-K 2.05 ↗
  • Feb 29, 24GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jan 24, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗
  • Jan 19, 24StructureEntered a material agreement+1 more in the same filing8-K 1.01 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • Redmile Group, LLC9.9%Apr 20, 26SCHEDULE 13G/A ↗4 co-filers on this document — the figure is the largest single stake, not their sum. · 3 earlier filings
  • Nantahala Capital Management, LLC9.7%Jun 30, 26SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Dr. Hans-Peter Wild9.6%May 15, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • TCG Crossover GP II, LLC9.2%Oct 27, 25SCHEDULE 13G ↗3 co-filers on this document — the figure is the largest single stake, not their sum.
  • Prosight Management, LP6.8%Dec 31, 25SCHEDULE 13G/A ↗5 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
show 4 more holdershide
  • BlackRock, Inc.5.4%Jun 30, 26SCHEDULE 13G ↗1 earlier filing
  • Oaktree Fund Administration, LLC4.1%Sep 30, 25SCHEDULE 13G/A ↗7 co-filers on this document — the figure is the largest single stake, not their sum.
  • Point72 Asset Management, L.P.4.0%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • ORBIMED CAPITAL LLC2.6%Dec 31, 25SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum.

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Apr 2, 26Sell$8.6MRedmile Group, LLC↗
  • Apr 2, 26Sell$8.3MRedmile Group, LLC↗
  • Apr 1, 26Sell$643KRedmile Group, LLC↗
  • Apr 1, 26Sell$617KRedmile Group, LLC↗
  • Mar 31, 26Sell$736KRedmile Group, LLC↗
  • Mar 31, 26Sell$707KRedmile Group, LLC↗
Stock compensation, tax and giftsshow the 34 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Jun 30, 26Compensationamount n/aAMEET MALLIKChief Executive Officer↗
  • Jun 30, 26Compensationamount n/aJose CarmonaChief Financial Officer↗
  • Jun 30, 26Compensationamount n/aPETER J GRAHAMChief Legal Officer↗
  • Jun 30, 26Compensationamount n/aMohamed ZakiChief Medical Officer↗
  • Jun 3, 26Tax$39KTimothy Coughlin↗
  • Jun 3, 26Tax$39KJEAN-PIERRE BIZZARI↗
  • Jun 3, 26Tax$7KPeter Hug↗
  • Jun 3, 26Tax$8KViviane Monges↗
  • Jun 3, 26Tax$39KVictor Sandor↗
  • Jun 3, 26Tax$47KRon Squarer↗
  • Jun 3, 26Tax$39KRobert Azelby↗
  • Jun 1, 26Compensationamount n/aTimothy Coughlin↗
  • Jun 1, 26Compensationamount n/aJEAN-PIERRE BIZZARI↗
  • Jun 1, 26Compensationamount n/aPeter Hug↗
  • Jun 1, 26Compensationamount n/aViviane Monges↗
  • Jun 1, 26Compensationamount n/aVictor Sandor↗
  • Jun 1, 26Compensationamount n/aRon Squarer↗
  • Jun 1, 26Compensationamount n/aRobert Azelby↗
  • Feb 13, 26Compensation$3.6MAMEET MALLIKChief Executive Officer↗
  • Feb 13, 26Tax$412KAMEET MALLIKChief Executive Officer↗
  • Feb 13, 26Compensation$1.1MJose CarmonaChief Financial Officer↗
  • Feb 13, 26Tax$103KJose CarmonaChief Financial Officer↗
  • Feb 13, 26Compensation$1.2MPETER J GRAHAMChief Legal Officer↗
  • Feb 13, 26Tax$133KPETER J GRAHAMChief Legal Officer↗
  • Feb 13, 26Compensation$1.1MMohamed ZakiChief Medical Officer↗
  • Feb 13, 26Tax$98KMohamed ZakiChief Medical Officer↗
  • Feb 13, 26Compensation$251KLisa Michelle KalleboChief Accounting Officer↗
  • Feb 13, 26Tax$22KLisa Michelle KalleboChief Accounting Officer↗
  • Dec 6, 25Tax$175KJose CarmonaChief Financial Officer↗
  • Dec 6, 25Tax$163KPETER J GRAHAMChief Legal Officer↗
  • Dec 6, 25Tax$23KLisa Michelle KalleboChief Accounting Officer↗
  • Dec 6, 25Tax$135KMohamed ZakiChief Medical Officer↗
  • Dec 6, 25Tax$767KAMEET MALLIKChief Executive Officer↗
  • Jun 13, 25Tax$45KRobert Azelby↗

The full record holds 90 transactions and goes back to Jan 2, 24.

Its sector and its market

ADC Therapeutics S.A. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From ADC Therapeutics S.A., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow ADC Therapeutics S.A. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
Series with incidents in the period; the chart shows what could be kept.
SEC records
392 documents on file, from Jul 25, 2019 to Oct 13, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

ADC Therapeutics S.A. (ADCT): stock price history, insider trades and SEC filings — HornScout